163 related articles for article (PubMed ID: 38141835)
21. Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
Halloran MO; Boyle C; Kehoe B; Bagkeris E; Mallon P; Post FA; Vera J; Williams I; Anderson J; Winston A; Sachikonye M; Sabin C; Boffito M
Antivir Ther; 2019; 24(3):193-201. PubMed ID: 30700636
[TBL] [Abstract][Full Text] [Related]
22. Weight gain following switch to integrase inhibitors from non-nucleoside reverse transcriptase or protease inhibitors in people living with HIV in the United States: analyses of electronic medical records and prescription claims.
Tse J; Prajapati G; Zhao X; Near AM; Kumar PN
Curr Med Res Opin; 2023 Sep; 39(9):1237-1246. PubMed ID: 37480288
[TBL] [Abstract][Full Text] [Related]
23. Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey.
Tinggaard M; David KP; Gerstoft J; Hansen AE; Kirk O; Lebech AM; Lindhardt BØ; Rose MV; Ryom L; Weis N; Benfield T
HIV Med; 2023 Jan; 24(1):46-54. PubMed ID: 35521975
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study.
Schlaeppi C; Vanobberghen F; Sikalengo G; Glass TR; Ndege RC; Foe G; Kuemmerle A; Paris DH; Battegay M; Marzolini C; Weisser M;
HIV Med; 2020 Jan; 21(1):53-63. PubMed ID: 31532898
[TBL] [Abstract][Full Text] [Related]
25. Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study.
Harding BN; Whitney BM; Nance RM; Crane HM; Burkholder G; Moore RD; Mathews WC; Eron JJ; Hunt PW; Volberding P; Rodriguez B; Mayer K; Saag MS; Kitahata MM; Heckbert SR; Delaney JAC
BMJ Open; 2020 Mar; 10(3):e031487. PubMed ID: 32198297
[TBL] [Abstract][Full Text] [Related]
26. Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years.
Şahin EA; Mavi D; Kara E; Sönmezer MÇ; İnkaya AÇ; Ünal S
Postgrad Med; 2022 Aug; 134(6):635-640. PubMed ID: 35671079
[TBL] [Abstract][Full Text] [Related]
27. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.
Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT;
J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401
[TBL] [Abstract][Full Text] [Related]
28. Risk and Cost Associated With Drug-Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France.
Demessine L; Peyro-Saint-Paul L; Gardner EM; Ghosn J; Parienti JJ
Open Forum Infect Dis; 2019 Mar; 6(3):ofz051. PubMed ID: 30949521
[TBL] [Abstract][Full Text] [Related]
29. Immune Reconstitution Inflammatory Syndrome in People Living with HIV Who Presented with Interstitial Pneumonitis: an Emerging Challenge in the Era of Rapid Initiation of Antiretroviral Therapy.
Chen KH; Liu WD; Sun HY; Lin KY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Cheng A; Hung CC
Microbiol Spectr; 2023 Mar; 11(2):e0498522. PubMed ID: 36877061
[TBL] [Abstract][Full Text] [Related]
30. Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors.
O'Halloran JA; Cooley SA; Strain JF; Boerwinkle A; Paul R; Presti RM; Ances BM
AIDS; 2019 Jul; 33(9):1477-1483. PubMed ID: 31008801
[TBL] [Abstract][Full Text] [Related]
31. Polypharmacy and Aging in People Living with HIV: 6 Years of Experience in a Multidisciplinary Outpatient Clinic.
Cattaneo D; Oreni L; Meraviglia P; Minisci D; Astuti N; Antinori S; Gori A; Gervasoni C
Drugs Aging; 2023 Jul; 40(7):665-674. PubMed ID: 37310576
[TBL] [Abstract][Full Text] [Related]
32. Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database.
Ruzicka DJ; Kuroishi N; Oshima N; Sakuma R; Naito T
BMC Infect Dis; 2019 Jun; 19(1):505. PubMed ID: 31182050
[TBL] [Abstract][Full Text] [Related]
33. High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction.
Cota JM; Benavides TM; Fields JD; Jansen N; Ganesan A; Colombo RE; Blaylock JM; Maves RC; Agan BK; Okulicz JF
PLoS One; 2021; 16(5):e0250607. PubMed ID: 33956843
[TBL] [Abstract][Full Text] [Related]
34. Potentially inappropriate medications in older adults living with HIV.
López-Centeno B; Badenes-Olmedo C; Mataix-Sanjuan A; Bellón JM; Pérez-Latorre L; López JC; Benedí J; Khoo S; Marzolini C; Calvo-Alcántara MJ; Berenguer J
HIV Med; 2020 Sep; 21(8):541-546. PubMed ID: 32516849
[TBL] [Abstract][Full Text] [Related]
35. The intersection of drug interactions and adverse reactions in contemporary antiretroviral therapy.
Nhean S; Tseng A; Back D
Curr Opin HIV AIDS; 2021 Nov; 16(6):292-302. PubMed ID: 34459470
[TBL] [Abstract][Full Text] [Related]
36. The management of polypharmacy in people living with HIV.
Marin S; Quiñones C; Codina-Jiménez C; Valls E; Terricabras E; Estrada L; Cardona G; Andreu À
AIDS Rev; 2023; 25(1):27-40. PubMed ID: 36952662
[TBL] [Abstract][Full Text] [Related]
37. Potential drug-drug interactions in the era of integrase strand transfer inhibitors: a cross-sectional single-center study in Japan.
Kunimoto Y; Matamura R; Ikeda H; Fujii S; Kimyo T; Kitagawa M; Nakata H; Kobune M; Miyamoto A; Fukudo M
J Pharm Health Care Sci; 2021 Dec; 7(1):43. PubMed ID: 34847955
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of compliance with PIMDINAC criteria among elderly people living with HIV and in non-infected outpatients with other chronic diseases.
Cantudo-Cuenca MD; Gutiérrez-Pizarraya A; García-Lloret P; Gabella-Bazarot E; Morillo-Verdugo R
Eur J Hosp Pharm; 2024 Jun; 31(4):339-343. PubMed ID: 36585218
[TBL] [Abstract][Full Text] [Related]
39. Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up.
Lin KY; Yang CJ; Sun HY; Lee YT; Liou BH; Hii IM; Chen TC; Huang SH; Lee CY; Tsai CS; Lin CY; Liu CE; Chang HY; Cheng CY; Lu PL; Hung CC;
Sci Rep; 2022 Sep; 12(1):16136. PubMed ID: 36167744
[TBL] [Abstract][Full Text] [Related]
40. Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19).
Lakatos B; Kowalska J; Antoniak S; Gokengin D; Begovac J; Vassilenko A; Wasilewski P; Fleischhans L; Jilich D; Matulionyte R; Kase K; Papadopoulus A; Rukhadze N; Harxhi A; Hofman S; Dragovic G; Vasyliev M; Verhaz A; Yancheva N; Oprea C;
HIV Med; 2022 Jul; 23(6):693-700. PubMed ID: 34859557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
